Sky View Investment Advisors, LLC Biocryst Pharmaceuticals Inc Transaction History
Sky View Investment Advisors, LLC
- $602 Million
- Q3 2024
A detailed history of Sky View Investment Advisors, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Sky View Investment Advisors, LLC holds 13,000 shares of BCRX stock, worth $101,140. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,000
Previous 10,000
30.0%
Holding current value
$101,140
Previous $62,000
59.68%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BCRX
# of Institutions
278Shares Held
172MCall Options Held
625KPut Options Held
739K-
Vanguard Group Inc Valley Forge, PA20.3MShares$158 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$155 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$92.3 Million1.36% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$70.7 Million5.66% of portfolio
-
State Street Corp Boston, MA8.85MShares$68.8 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.45B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...